TG Therapeutics Reports In Form4 Filing CEO And President Michael Weiss Buys 100K Shares At Average Price Of $10.13/Share
Portfolio Pulse from Benzinga Newsdesk
TG Therapeutics' CEO and President, Michael Weiss, has purchased 100,000 shares of the company at an average price of $10.13 per share, according to a Form4 filing with the SEC.
August 14, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TG Therapeutics' CEO has shown confidence in the company by purchasing 100,000 shares. This could potentially boost investor confidence and positively impact the stock price in the short term.
Insider buying is often seen as a positive sign as it indicates that those with the most insight into the company believe its stock is a good investment. This could potentially lead to increased investor confidence and a rise in stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100